Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-047608)

Filing Details

Accession Number:: 0001209191-13-047608
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-10-07 15:19:37
Reporting Period:: 2013-03-12

Filing Date:: 2013-10-07
Accepted Time:: 2013-10-07 15:19:37
Original Submission Date:: 2013-03-14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
949858	Oncogenex Pharmaceuticals Inc.	OGXI	In Vitro & In Vivo Diagnostic Substances (2835)	954343413

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1442675	Daniel Scott Cormack	400-1001 W. Broadway Vancouver A1 V6H 4B1	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-03-12	2,134	$11.90	56,788	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This amended Form 4 is filed to correct the transaction code, which was previously inadvertently reported as "F", and the sales price. The sales reported on this amended Form 4 were made for the sole purpose of covering the reporting person's tax liability in connection with the settlement of RSUs on March 12, 2013, which transaction was previously reported.